To include your compound in the COVID-19 Resource Center, submit it here.

Transgene reorganizes

Transgene (TRGNY; NM:Transgene) said it will focus R&D efforts on its cancer immunotherapy product candidates,

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE